| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Galera Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 64K | Jun 14, 2023 | Direct | ||
| Checkmate Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | May 31, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Director |
| GRTX | Galera Therapeutics, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| GRTX | Galera Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| CMPI | Checkmate Pharmaceuticals, Inc. | May 31, 2022 | 3 | $0 | 4 | May 31, 2022 | Director |
| CMPI | Checkmate Pharmaceuticals, Inc. | Aug 9, 2021 | 1 | $0 | 4 | Aug 10, 2021 | Director |
| CMPI | Checkmate Pharmaceuticals, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
| GRTX | Galera Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |